Arbor Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Arbor Pharmaceuticals's estimated annual revenue is currently $22.5M per year.
- Arbor Pharmaceuticals's estimated revenue per employee is $201,000
- Arbor Pharmaceuticals's total funding is $40.4M.
Employee Data
- Arbor Pharmaceuticals has 112 Employees.
- Arbor Pharmaceuticals grew their employee count by -7% last year.
Arbor Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $24.5M | 122 | 8% | N/A | N/A |
#2 | $10.7M | 53 | -17% | N/A | N/A |
#3 | $9.2M | 46 | 2% | N/A | N/A |
#4 | $24.1M | 120 | 5% | N/A | N/A |
#5 | $7.2M | 36 | -20% | N/A | N/A |
#6 | $27.7M | 138 | -30% | N/A | N/A |
#7 | $39.8M | 198 | 37% | N/A | N/A |
#8 | $0.5M | 5 | 25% | $50M | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $10.3M | 51 | 11% | N/A | N/A |
What Is Arbor Pharmaceuticals?
Arbor Pharmaceuticals is dedicated to introducing and growing unique pharmaceutical brands that have features closely aligned with those desired by pediatricians and their patients. Specifically, Arbor will initially focus on acute care medicines that incorporate well characterized (safe and effective) molecules with novel delivery systems to enhance the product profile.
keywords:N/A
$40.4M
Total Funding
112
Number of Employees
$22.5M
Revenue (est)
-7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Arbor Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Cardiovascular Sales Specialist | Reveal Email/Phone |
3 | Hospital Specialty Manager DFW/West Texas/ NM | Reveal Email/Phone |
4 | Senior Territory Manager | Reveal Email/Phone |
5 | Professional Territory Manager | Reveal Email/Phone |
6 | Territory Manager | Reveal Email/Phone |
7 | Neuroscience Specialist/Certified Field Trainer | Reveal Email/Phone |
8 | Pharmaceutical Sales Representative | Reveal Email/Phone |
9 | Territory Manager | Reveal Email/Phone |
10 | Executive Territory Business Manager | Reveal Email/Phone |
Arbor Pharmaceuticals News
NovaQuest Capital's Azurity Pharmaceuticals Inc., its Arbor unit, and their business partner, Morgan Stanley's Comar LLC, filed a lawsuit...
Merck. Co., Inc, Galderma Laboratories, L.P., Arbor Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Medicines Development for Global...
"Plaintiffs Arbor Pharmaceuticals LLC and Takeda Pharmaceutical Co. Ltd., and defendants Lupin Ltd. and Lupin Pharmaceuticals Inc.,...
Arbor Pharmaceuticals, an Atlanta, GA-based specialty pharmaceutical company, completed a $34.8m financing. This included a $17.5m investment in the form of Series B Preferred Stock led by Signet Healthcare Partners, LLC. The remainder of the financing was provided in the form of a term loan by ...
Other Companies in Sandy Springs
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $28.5M | 114 | 0% | N/A |
#2 | $16.8M | 116 | 5% | N/A |
#3 | $24.5M | 122 | 8% | N/A |
#4 | $34M | 126 | 42% | N/A |
#5 | $33.1M | 132 | 4% | N/A |
Arbor Pharmaceuticals Executives
| Name | Title |
|---|---|
| Ed Schutter | CEO |
| Kevin Guthrie | Vice-President Commercial Operations |
| Steven Caras | Vice President |
| Mary Lou Freathy | V.P. Regulatory Affairs, Quality, and Manufacturing |